These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 20149748)
21. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome. Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466 [TBL] [Abstract][Full Text] [Related]
22. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938 [TBL] [Abstract][Full Text] [Related]
23. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685 [TBL] [Abstract][Full Text] [Related]
24. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas]. Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma. Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995 [TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433 [TBL] [Abstract][Full Text] [Related]
27. [Primary breast lymphoma--a report of 27 cases with literature review]. Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374 [TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155 [TBL] [Abstract][Full Text] [Related]
29. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience. Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844 [TBL] [Abstract][Full Text] [Related]
30. New REAL clinical entities. Fisher RI; Miller TP; Grogan TM Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769 [TBL] [Abstract][Full Text] [Related]
31. Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification. Monabati A; Safaei A; Noori S; Mokhtari M; Vahedi A Ann Hematol; 2016 Mar; 95(4):613-8. PubMed ID: 26754635 [TBL] [Abstract][Full Text] [Related]
32. Lymphoma--histopathology in changing clinical perspective. Non-Hodgkin's Lymphoma Classification Project. Jacobs P S Afr Med J; 2000 Feb; 90(2):135-41. PubMed ID: 10745967 [TBL] [Abstract][Full Text] [Related]
33. [Lymphomas in children and adolescents]. Brugières L; Minard V; Patte C Rev Prat; 2012 Apr; 62(4):453-8. PubMed ID: 22641877 [TBL] [Abstract][Full Text] [Related]
34. Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Naresh KN; Raphael M; Ayers L; Hurwitz N; Calbi V; Rogena E; Sayed S; Sherman O; Ibrahim HA; Lazzi S; Mourmouras V; Rince P; Githanga J; Byakika B; Moshi E; Durosinmi M; Olasode BJ; Oluwasola OA; Akang EE; Akenòva Y; Adde M; Magrath I; Leoncini L Br J Haematol; 2011 Sep; 154(6):696-703. PubMed ID: 21707579 [TBL] [Abstract][Full Text] [Related]
35. The changing incidence of lymphoproliferative disorders in Yorkshire. Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676 [TBL] [Abstract][Full Text] [Related]
36. Immunophenotypic classification of lymphoblastic leukaemia and lymphocytic lymphoma--an experience in the south-western area of the Cape Province of South Africa. Jacobs P Leuk Res; 1985; 9(6):755-63. PubMed ID: 3874333 [TBL] [Abstract][Full Text] [Related]
37. The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study). Govi S; Christie D; Mappa S; Marturano E; Bruno-Ventre M; Messina C; Medina EA; Porter D; Radford J; Heo DS; Park Y; Pro B; Jayamohan J; Pavlakis N; Zucca E; Gospodarowicz M; Ferreri AJ; Leuk Lymphoma; 2014 Aug; 55(8):1796-9. PubMed ID: 24295130 [TBL] [Abstract][Full Text] [Related]